Photodynamic diagnosis and therapy in dermatology

Skin Pharmacology and Applied Skin Physiology

Volumn 11, Issue 6, 1998, Pages 358-373

  Fritsch, C ^a   Lang, K ^a   Neuse, W ^a   Ruzicka, T ^a   Lehmann, P ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

aminolevulinic acid; Inflammatory skin diseases; Photodiagnosis; Photodynamic diagnosis; Photodynamic therapy; Porphyrin fluorescence; Skin tumors

Indexed keywords

AMINOLEVULINIC ACID; FREE RADICAL; PHOTOSENSITIZING AGENT; PORPHYRIN; SINGLET OXYGEN;

ACTINIC KERATOSIS; ARTICLE; BASAL CELL CARCINOMA; CELL DEATH; DERMATOLOGY; DIAGNOSTIC APPROACH ROUTE; FLUORESCENCE; HISTOPATHOLOGY; HUMAN; IRRADIATION; PHOTODYNAMIC THERAPY; PRECANCER; PRIORITY JOURNAL; PSORIASIS; SKIN CANCER; SKIN DISEASE; SQUAMOUS CELL CARCINOMA; TOPICAL DRUG ADMINISTRATION;

AMINOLEVULINIC ACID; FLUORESCENCE; HUMANS; PHOTOSENSITIZING AGENTS; PHOTOTHERAPY; PORPHYRINS; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 0032449312     PISSN: 14222868     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029858     Document Type: Article

References (16)

1. Raab O: Über die Wirkung fluorescierender Stoffe auf Infusoriera. Z Biol 1900;39:524.
2. von Tappeiner H, Jesionek A: Therapeutische Versuche mit fluoreszierenden Stoffen. MMW 1903;50:2042-2044.
3. Jesionek A, von Tappeiner H: Zur Behandlung von Hautcarcinomen mit fluorescierenden Stoffen. Arch Klin Med 1905;82:72-76.
4. Policard A: Etude sur les aspects offerts par des tumeurs expérimentales examinées à la lumière de Wood. C R Soc Biol 1924;91:1423-1424.
5. Figge FHJ, Weiland GS, Manganiello LOJ: Cancer detection and therapy: Affinity of neoplastic, embryonic, and traumatized tissues for porphyrins and metalloporphyrins. Proc Soc Exp Biol Med 1948;68:640-641.
6. Rassmusen-Taxdal DS, Ward GE, Figge FHJ: Fluorescence of human lymphatic and cancer tissues following high doses of hematoporphyrin. Cancer 1955;8:78-83.
7. Gregorie HG Jr, Horger EO, Ward JL: Hematoporphyrin-derivative fluorescence in malignant neoplasms. Ann Surg 1968;167:820-828.
8. Pass HI: Photodynamic therapy in oncology: Mechanisms and clinical use. J Natl Cancer Inst 1993;85:443-456.
9. Kennedy JC, Pottier RH, Pross DC: Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience. J Photochem Photobiol [B] 1990;6:143-148.
10. Fritsch C, Goerz G, Ruzicka T: Photodynamic therapy in dermatology. A review. Arch Dermatol 1998;134:207-214.
11. Cairnduff F, Stringer MR, Hudson EJ, Ash DV, Brown SB: Superficial photodynamic therapy with topical 5-aminolevulinic acid for superficial primary and secondary skin cancer. Br J Cancer 1994;69:605-608.
12. Fritsch C, Becker-Wegerich PM, Schulte KW, Neuse W, Lehmann P, Ruzicka T, Goerz G: Treatment of a large superficial basal cell carcinoma of the breast with combination of photodynamic therapy and surgery controlled by photodynamic diagnosis. Hautarzt 1996;47:438-442.
13. Fijan S, Hönigsmann H, Ortel R: Photodynamic therapy of epithelial skin tumors using delta-aminolevulinic acid and desferrioxamine. Br J Dermatol 1995;133:282-288.
14. Wolf P, Rieger E, Kerl H: Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid: An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas? J Am Acad Dermatol 1993;28:17-21.
15. Calzavara-Pinton PG: Repetitive photodynamic therapy with topical δ-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumors. J Photochem Photobiol [B] 1995;29:53-57.
16. Fritsch C, Stege H, Saalmann G, Goerz G, Ruzicka T, Krutmann J: Green light is effective and less painful than red light in photodynamic therapy of actinic keratoses. Photodermatol Photoimmunol Photomed 1997;13:181-185.